Tamar Thompson's Insider Trades & SAST Disclosures
Tamar Thompson's most recent trade in Catalyst Pharmaceuticals Inc was a trade of 1,413 Common Stock, par value $0.001 per share done . Disclosure was reported to the exchange on Dec. 9, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Tamar Thompson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Catalyst Pharmaceuticals Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 1,413 | 1,413 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 1,413 | 98,440 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 23,248 | 97,012 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 2,841 | 99,853 | - | - | Restricted Stock Units | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.63 per share. | 07 Oct 2024 | 30,000 | 30,000 | - | 27.6 | 828,900 | Common Stock |
| Avidity Biosciences Inc | Tamar Thompson | Director | Sale of securities on an exchange or to another person at price $ 44.98 per share. | 07 Oct 2024 | 30,000 | 0 | - | 45.0 | 1,349,259 | Common Stock |
| Avidity Biosciences Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 13,489 | 13,490 | - | - | Stock Option (Right to Buy) | |
| Catalyst Pharmaceuticals Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 29,524 | 69,524 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Thompson Tamar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 4,240 | 73,764 | - | - | Restricted Stock Units | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges